Assessing the Impact of Differential Genotyping Errors on Rare Variant Tests of Association by Mayer-Jochimsen, Morgan et al.
Digital Collections @ Dordt
Faculty Work: Comprehensive List
3-2013
Assessing the Impact of Differential Genotyping




Massachusetts Institute of Technology
Nathan L. Tintle
Dordt College, nathan.tintle@dordt.edu
Follow this and additional works at: http://digitalcollections.dordt.edu/faculty_work
Part of the Bioinformatics Commons, Genetics and Genomics Commons, and the Statistics and
Probability Commons
This Article is brought to you for free and open access by Digital Collections @ Dordt. It has been accepted for inclusion in Faculty Work:
Comprehensive List by an authorized administrator of Digital Collections @ Dordt. For more information, please contact ingrid.mulder@dordt.edu.
Recommended Citation
Mayer-Jochimsen M, Fast S, Tintle NL (2013) Assessing the Impact of Differential Genotyping Errors on Rare Variant Tests of
Association. PLoS ONE 8(3): e56626. doi:10.1371/journal.pone.0056626
Assessing the Impact of Differential Genotyping Errors on Rare Variant
Tests of Association
Abstract
Genotyping errors are well-known to impact the power and type I error rate in single marker tests of
association. Genotyping errors that happen according to the same process in cases and controls are known as
non-differential genotyping errors, whereas genotyping errors that occur with different processes in the cases
and controls are known as differential genotype errors. For single marker tests, non-differential genotyping
errors reduce power, while differential genotyping errors increase the type I error rate. However, little is
known about the behavior of the new generation of rare variant tests of association in the presence of
genotyping errors. In this manuscript we use a comprehensive simulation study to explore the effects of
numerous factors on the type I error rate of rare variant tests of association in the presence of differential
genotyping error. We find that increased sample size, decreased minor allele frequency, and an increased
number of single nucleotide variants (SNVs) included in the test all increase the type I error rate in the
presence of differential genotyping errors. We also find that the greater the relative difference in case-control
genotyping error rates the larger the type I error rate. Lastly, as is the case for single marker tests, genotyping
errors classifying the common homozygote as the heterozygote inflate the type I error rate significantly more
than errors classifying the heterozygote as the common homozygote. In general, our findings are in line with
results from single marker tests. To ensure that type I error inflation does not occur when analyzing next-
generation sequencing data careful consideration of study design (e.g. use of randomization), caution in meta-
analysis and using publicly available controls, and the use of standard quality control metrics is critical.
Keywords
Genotyping, alleles, phylogeography, variant genotypes, sequence analysis
Disciplines
Bioinformatics | Genetics and Genomics | Statistics and Probability
Comments
Copyright © 2013 Mayer-Jochimsen et al. This is an open-access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are credited.
This article is available at Digital Collections @ Dordt: http://digitalcollections.dordt.edu/faculty_work/111
Assessing the Impact of Differential Genotyping Errors
on Rare Variant Tests of Association
Morgan Mayer-Jochimsen1, Shannon Fast2, Nathan L. Tintle3*
1Department of Mathematics, Scripps College, Claremont, California, United States of America, 2Department of Operations Research, Massachussets Institute of
Technology, Boston, Massachusetts, United States of America, 3Department of Mathematics, Statistics and Computer Science, Dordt College, Sioux Center, Iowa, United
States of America
Abstract
Genotyping errors are well-known to impact the power and type I error rate in single marker tests of association.
Genotyping errors that happen according to the same process in cases and controls are known as non-differential
genotyping errors, whereas genotyping errors that occur with different processes in the cases and controls are known as
differential genotype errors. For single marker tests, non-differential genotyping errors reduce power, while differential
genotyping errors increase the type I error rate. However, little is known about the behavior of the new generation of rare
variant tests of association in the presence of genotyping errors. In this manuscript we use a comprehensive simulation
study to explore the effects of numerous factors on the type I error rate of rare variant tests of association in the presence of
differential genotyping error. We find that increased sample size, decreased minor allele frequency, and an increased
number of single nucleotide variants (SNVs) included in the test all increase the type I error rate in the presence of
differential genotyping errors. We also find that the greater the relative difference in case-control genotyping error rates the
larger the type I error rate. Lastly, as is the case for single marker tests, genotyping errors classifying the common
homozygote as the heterozygote inflate the type I error rate significantly more than errors classifying the heterozygote as
the common homozygote. In general, our findings are in line with results from single marker tests. To ensure that type I
error inflation does not occur when analyzing next-generation sequencing data careful consideration of study design (e.g.
use of randomization), caution in meta-analysis and using publicly available controls, and the use of standard quality control
metrics is critical.
Citation: Mayer-Jochimsen M, Fast S, Tintle NL (2013) Assessing the Impact of Differential Genotyping Errors on Rare Variant Tests of Association. PLoS ONE 8(3):
e56626. doi:10.1371/journal.pone.0056626
Editor: Zhaoxia Yu, University of California, Irvine, United States of America
Received September 26, 2012; Accepted January 15, 2013; Published March 5, 2013
Copyright:  2013 Mayer-Jochimsen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which
permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was funded by the National Human Genome Research Institute (R15HG004543; R15HG006915). The funders had no role in study design, data
collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: nathan.tintle@dordt.edu
Introduction
In anticipation of a tidal wave of next-generation sequencing
data from large case-control studies, numerous statistical tests
intended to boost statistical power have been proposed. These tests
attempt to aggregate genotype-phenotype association across
numerous single nucleotide variant sites in a region of interest
[1–11]. This new class of ‘‘rare variant tests’’ is beginning to be
applied to real sequence data, as well to both imputed and
genotype array data. However, aside from in silico simulation
studies comparing the methods, relatively little is known about the
behavior of these methods on real sequence data.
One of the first, large-scale attempts to understand rare variant
tests when applied to real sequence data was at Genetic Analysis
Workshop 17 where analyses revealed that existing rare variant
tests perform poorly on real sequence data: with both increased
type I errors and low statistical power [12]. Numerous potential
explanations for the poor performance have been suggested
including population stratification, gametic phase disequilibrium
between causal and non-causal variants and genotyping errors–
both differential and non-differential [13–16]. Recently, other
simulation [17] and mathematical [Liu et al., unpublished
manuscript] analyses have attempted to better understand the
behavior of these tests.
Addressing population stratification, gametic phase disequilib-
rium and other related issues likely amount to analytic challenges
which will be solved as methods for the analysis of sequence data
mature. However, genotyping errors, long known to impact power
and type I error in single marker (common variant) tests of
genotype-phenotype association, have typically been robust to
analytic advances, unless alternative study designs are employed
[18–20]. Thus, it is useful to consider the impact of genotyping
errors on current rare variant tests of association.
For single marker tests, when genotyping errors occur according
to an error process that is unrelated to the phenotype (non-
differential genotype errors), power loss is observed [21–26].
Recently, we considered the impact of non-differential genotype
errors on rare variant tests of association [27]. We found that even
at very low genotype error rates, misclassifying common homo-
zygotes as heterozygotes translates into substantial power loss for
rare variant tests, an effect that is magnified as the minor allele
frequency (MAF) at the site decreases. Additionally, we demon-
strated that at low error rates, heterozygote to homozygote errors
have little impact on power. Heterozygote to (common) homozy-
PLOS ONE | www.plosone.org 1 March 2013 | Volume 8 | Issue 3 | e56626
gote errors can be common in practice, and, at moderate to large
error rates, can also substantially impact power.
Differential errors, genotyping errors that result from a process
that is different for cases and controls, are well-known to inflate the
type I error for single marker tests of association [28,29].
Specifically, Ahn et al. [29] found that type I errors increase as
MAF decreases, as differential errors coding more common to less
common genotypes increase, and as sample size increases.
However, no work has been done to explore the impact of
differential genotyping errors on the new class of rare variant tests
of association. Since low MAF markers are the most prone to type
I errors from differential genotyping errors and rare variant tests
are, by their very nature, focused on the rarest of variants, it is
especially prudent to explore the impact of differential error on
rare variant tests.
There are numerous plausible explanations for differential error
processes in rare variant data. As is the case for single-marker tests
of association, without good study designs which ensures random
assignment of samples to sequencing centers, to individuals
handling the samples, to sequencing machines, etc., genotyping
errors can easily occur at different rates in the cases and controls.
One particular area of concern is the increasing trend to use
publicly available databases of controls. When using publicly
available databases, there is no random assignment of cases and
controls to sequencing pipelines, thus there are numerous ways
that differential genotyping errors can be introduced. Further-
more, even if publicly available datasets are simply being used to
impute rare variants, the potential for differential genotyping
imputation error exists. Similarly, when using a Bayesian prior
based on the known MAF at the variant site to call rare genotypes
there is a potential for differential genotyping errors when the
Bayesian prior favors variants observed more frequently in the
cases or controls.
In this manuscript, we conduct a comprehensive simulation
study to evaluate the extent to which differential genotyping errors
impact the type I error rate of five recently proposed rare variant
tests of association. We also evaluate the factors associated with
increased type I error rate in rare variant tests of association.
Methods
Simulation of Genotypes and Phenotypes
The methods used to simulate genotypes in this study have been
described elsewhere [27].We provide a brief overview here. We
considered a total of four different genotype distributions at the
locus of interest. Namely, all possible combinations of the
following two parameters: Low/High number of single nucleotide
variants (SNVs; 8 or 64 at the locus) and Low/High MAF of the
SNVs at the locus (0.1%/1% or 0.5%/5%). At each locus L of
the SNVs are more common (1% or 5% MAF), and J are less
common (0.1% or 0.5%). Genotypes were simulated indepen-
dently and assuming Hardy-Weinberg Equilibrium. Sample sizes
(sets of genotypes) of 1000, 2000 and 3000 were considered for
each genotype distribution (for a total of 463=12 sample size/
genotype distribution combinations). Simulated genotypes (repre-
senting individuals) were randomly assigned as cases or controls (in
equal proportion), in line with the null hypothesis that the locus is
not related to the dichotomous disease phenotype.
Simulating Differential Genotype Errors
Because the focus of our analysis is on rare variants, we only
considered genotyping errors between the common homozygote
and the heterozygote. Let e01= the probability that an individual
who is actually the common homozygote is misclassified as the
heterozygote, and let e10= the probability that an individual who is
actually the heterozygote is misclassified as the common homo-
zygote. We considered three types of error models in the main
simulation, with additional settings considered in an additional
simulation (see Additional simulation settings). The three main error
models considered were (a) Homozygote to heterozygote errors
only (e01 = e and e10=0), (b) Heterozygote to Homozygote errors
only (e01 = 0 and e10= e) and (c) Both errors present (e01= e10= e).
We considered three different values for e in the controls: 0.1%,
1% and 5%. To simulate differential errors, the value of e in the
cases was then increased to e+0.1%, e+0.5% or e+1%. Thus, in
total, the main simulation analysis considers 324 total settings: all
possible combinations of the 6 factors (# SNPs (8 or 64), MAF
(0.1%/1% or 0.5%/5%, sample size (1000, 2000 or 3000),
magnitude of errors (0.1%, 1% or 5%), error model (e01 only, e10
only or both e10 and e01) and differential effect in cases (0.1%,
0.5% or 1%)).
Additional Simulation Settings
Recognizing that because of the nature of genotype calling
algorithms, it is likely that the heterozygote to homozygote error
rate (e10) may be much larger than the homozygote to
heterozygote error rate (e01) we conducted a small additional
simulation study considering error rates reflecting this. Specifically,
as in Powers et al. [27], we let e10 = 10e01. For this small
simulation study, we consider only a sample size of 2000
individuals (1000 cases and 1000 controls), either 8 or 32 SNVs
where L of the SNV’s have MAF=0.001, and J have
MAF=0.01. Furthermore, we investigated three different combi-
nations of genotyping error rates in the controls: 0.1%/1% (e01/
e10), 1%/10% and 5%/50%. To introduce differential error we
increased each error rate, considering four different options:
e01+0.1% and e10+0.1%, e01+0.3% and e10+0.3%, e01+0.5% and
e10+0.5%, and e01+1% and e10+1% in the cases. Thus, we
considered a total of 24 settings; all possible combinations of
number of SNVs (8 or 32), control genotype error rate (0.001/
0.01, 0.01/0.10, 0.05/0.5), and differential case error rate
(magnitude of change 0.1%, 0.3%, 0.5% or 1%).
Rare Variant Tests Used to Analyze Data
This paper examines the effects of differential genotyping
error through consideration of five commonly used rare variant
tests of association: Combined Multivariate and Collapsing
(CMC) [1], Weighted-Sum (WS) [2], Proportion Regression
(PR) [5], Cumulative Minor Allele Test (CMAT) [7], and
Sequence Kernel Association Test (SKAT) [11]. These methods
are all described in detail in the original papers proposing these
methods, with our specific implementations of the first four
methods described in Powers et al. [27]. In the following
sections we briefly describe each method, and explain our
implementation of SKAT.
CMC
The combined multivariate and collapsing (CMC) test aggre-
gates mutations at rare variant sites within a defined region
according a threshold defined a priori (here, all sites were
aggregated since we only consider rare variation; MAF,5%).
Each individual is assigned a dichotomous variable representing
their status across all sites at the locus: a 0 if all sites are wildtype
and a 1 if one or more rare variants are present in the region. The
asymptotic distribution of Hotelling’s T2 is used to evaluate
statistical significance.
Impact of Differential Errors
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WS
The weighted sum (WS) method employs a weighting scheme
to increase the signal of the rarest variants. A weight is
calculated for each variant site by estimating the standard
deviation of the total number of mutations in controls. Each
individual is assigned a score that is the sum of the number of
minor alleles divided by the weight at each site. Individuals are
ranked according to their score. The test statistic is the sum of
the rankings of case individuals. Statistical significance is
assessed using a permutation approach with 1000 permutations
of case/control status.
PR
In proportion regression (PR), disease status is regressed on
a single covariate representing the percentage of sites at the locus
which possess a rare variant for the individual. We used logistic
regression and the asymptotic distribution of the likelihood ratio
statistic to assess statistical significance.
CMAT
The cumulative minor allele test (CMAT) counts the total
number of rare/common alleles within the locus of interest for
both cases and controls and uses a test statistic similar in spirit to
a Pearson chi-squared test, where permutation is used to assess
statistical significance since individuals can contribute multiple
counts.
SKAT
The sequence kernel association test (SKAT) uses a multiple
regression model to directly regress the phenotype on genetic
variants at the locus. SKAT analyzes the regression coefficients of
the variants using a variance component score test using an
unweighted linear kernel. P-values are computed analytically. We
used the R package provided by the authors of SKAT to generate
p-values for our analysis.
Computing Type I Error
1000 separate simulations of each of the 324 parameter settings
in the main simulation study, along with 1000 simulations of the
each of the 24 settings in the additional simulation analysis, were
used to assess the type I error rate. The type I error rate was
assessed as the proportion of the 1000 simulations generating p-
values less than 0.05.
Results
Overall Assessment of Type I Error Rate Inflation
Across the 324 settings and five rare variant tests, the
estimated type I error rate ranged from 1.2% to 100%.
However, for each of the five tests, the majority of simulation
settings showed meaningfully increased type I error, which we
define as a type I error rate above 6.1% (a value which should
occur less than 5% of the time by random chance if the true
type I error rate is actually 5%). Specifically, for CMC, 62.7%
of the 324 settings showed a type I error rate above 6.1%, with
similar values for the other four tests (WS 67.6%, PR 69.8%,
CMAT 77.5%, SKAT 56.2%). Simulations with no genotype
errors but other simulation parameters related to those
considered in this manuscript, show either control or slight
conservatism in the empirical nominal type I error rate for
CMC, WS, PR, and CMAT (Powers et al. 2011). SKAT shows
similar patterns (detailed results not shown).
Impact of Different Factors on Type I Error Rate
In order to understand, generally, how the type I error rate is
affected by each of the six simulation parameters, we fit five
separate multiple regression models: one for each rare variant test.
The model predicted the observed type I error rate by each of the
six simulation parameters (where we used relative amount of
differential expression, case error rate divided control error rate,
instead of magnitude of differential error). Model r2 values ranged
from 41 to 56% suggesting that the main effects of the six
simulation parameters explained the approximately half of the
total change observed in the type I error rate.
Table 1 gives the seven coefficients corresponding to the six
simulation parameters (there two coefficients for the error model
parameter since we use indicator variables) for each of the five rare
variant tests. Five of the seven coefficients are significant in each
model, suggesting that most simulation factors directly impact the
type I error rate. We provide a brief interpretation of the
coefficients from Table 1 here. The impact of sample size was
positive for all tests, meaning that as sample size increases, type I
error rate increases for all tests. Across the settings considered
here, type I error increased by between 3.7 to 6.3% for each
additional 1000 individuals in the study.
The Type I error rate also increased as the number of variants
increased for all tests. Specifically, for each additional variant
added to the test (for which the same differential error model is
true), the type I error rate increased between 0.14 and 0.34%.
The impact on type I error rate lessened as the minor allele
frequency increased. Specifically, for every 1% increase in minor
allele frequency the type I error rate decreased by approximately
7.9 to 12.0%.
As expected, the relative amount of differential error is strongly
associated with the observed type I error rate. Namely, as the
relative amount of differential error increased, the type I error rate
increased. For example, if the relative amount of genotype error
(case error rate/control error rate) increases from 2 to 3 (e.g., goes
from 2%/1% to 3%/1%), the type I error rate increases by
approximately 2.5 and 3.7%. Because we used the relative
differential error in our model, the control error rate showed
little effect on type I error rate.
The error model coefficients are based on indicator variables.
The coefficient for the e10 only model shows that there is a smaller
increase in type I error rate when only e10 errors occur than when
both e10 and e01 errors occur. Additionally, there is not a significant
difference between the e01 only error model and the both errors
model. The difference in effect is estimated to be between 42%
and 63% more type I errors in either model that contains
homozygote to heterozygote errors, as compared to a model with
only heterozygote to homozygote errors.
Figures 1, 2, and 3 illustrate the observed type I error rate
(averaged across all simulation settings) for each of the five tests,
and for each of the nine combinations of case and control error
rates. Differential genotyping error, even in low amounts (0.2%)
can substantially increase the type I error rate for all five tests.
As suggested by the multiple regression models, there is
a significant impact of sample size on the type I error rate of the
different tests. Figure 4 illustrates how the magnitude of the
differential errors and the sample size combine to impact the type I
error rate. Similar graphs are obtained for all five rare variant tests
and other simulation settings (details not shown).
Analysis of Additional Simulation Settings
As noted earlier, in addition to the main simulation study which
covered 324 settings, we also conducted a small simulation study
covering 24 settings, which were selected to reflect genotyping
Impact of Differential Errors
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error patterns that may be observed based on current genotype
calling algorithms. Figures 5 and 6 each illustrate the type I error
rate for four of the twenty-four settings. In each case, we see that
even for very small amounts of differential genotyping error,
substantially inflated type I errors can be observed. Additional
figures showing similar patterns for differential error models with
higher error rates show similar patterns (see Figures 7, 8, 9, and 10
for details).
Discussion
Our results demonstrate the potential for inflation of the type I
error rate in a variety of error models, across five commonly used
rare variant tests of association. Furthermore, as has been
demonstrated for single marker tests of association, increasing
the sample size and decreasing the minor allele frequency both
inflate the type I error rate. Additionally, since rare variant tests
aggregate across multiple sites, increasing the number of SNVs for
which differential genotyping error is present increases the type I
error. Lastly, as has been demonstrated for single marker tests,
differential errors which increase homozygote to heterozygote
genotyping errors are particularly detrimental.
Our results also demonstrate that increasing the relative amount
of the differential error inflates the type I error rate, while we did
not find strong evidence of an effect of the control genotyping
error rate. While we only considered three settings for the control
error rate, these results are interesting because they suggest that
even low amounts of genotyping error can be problematic if the
relative differential genotyping error is large (e.g., low error rates
of 0.1% in controls and 1.0% in cases, but large relative
differential error value of 10= 1%/0.1%).
Intuitively, type I errors are introduced from differential
genotyping errors, because, under the null hypothesis of no
association between the locus and the phenotype, the allele
frequency distributions are identical. Non-differential genotyping
errors do not increase the type I error rate, because the allele
Table 1. Coefficients from regression models predicting type I error rate.
Parameter CMC WS PR CMAT SKAT
Sample Size 5.661025*** 3.761025* 4.161025** 4.361025** 6.361025***
Number of variants 1.461023** 3.261023*** 3.461023*** 3.161023*** 2.961023***
MAF 29.961022*** 27.961022** 28.361022** 29.561022*** 21.261021***
Relative amount of differential
error
3.161022*** 2.561022*** 2.961022*** 2.761022*** 3.761022***
Error rate in controls 21.9* 6.2 7.9 7.6 1.1
Error model e01 only 21.6610
22 21.861022 21.861022 21.761022 27.061023





Figure 1. Type I error rate when error rate in controls is 0.10%. The observed type I error rate, averaged across all simulation settings, for
each of the five rare variant tests (CMC, WS, PR, CMAT and SKAT). Differential genotyping error can be substantial, even at low error rates.
doi:10.1371/journal.pone.0056626.g001
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frequency distributions remain the same for cases and controls.
However, differential genotyping errors introduce a difference
between the case-control allele frequencies, in the same manner as
if there were a true genotype-phenotype association at the locus.
Because differential genotype errors manifest themselves as
different allele frequency distributions between cases and controls,
all of the variables that impact the power of a rare variant test of
association will also impact the type I error rate in the presence of
differential genotyping error. Specifically, increasing the sample
size will increase the power for testing a true effect, just as it
increases the type I error in the presence of differential genotyping
errors. Similarly, the relative amount of differential genotyping
errors, the number of SNVs at the locus, the MAF and the type of
errors observed (homozygote to heterozygote or vice versa) are all
related to type I errors.
Figure 2. Type I error rate when error rate in controls is 1%. The observed type I error rate, averaged across all simulation settings, for each of
the five rare variant tests (CMC, WS, PR, CMAT and SKAT). Modest levels of differential genotyping error rates can substantially increase the type I error
rate.
doi:10.1371/journal.pone.0056626.g002
Figure 3. Type I error rate when error rate in controls is 5%. The observed type I error rate, averaged across all simulation settings, for each of
the five rare variant tests (CMC, WS, PR, CMAT and SKAT). High levels of differential genotyping errors can substantially increase the type I error rate.
doi:10.1371/journal.pone.0056626.g003
Impact of Differential Errors
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This intuition helps to not only explain why certain factors are
related to the type I error rate, but also points to areas of concern
and caution for researchers today. For example, increasingly
researchers are turning to meta-analytic techniques and combin-
ing datasets across multiple labs, or using publicly available
controls. The goal, of course, is to increase power by increasing
sample size. A significant concern raised by our analysis is that if
different error processes are present in the samples in a manner
associated with the phenotype, there is the potential for significant
type I error problems.
As noted in the text, there were also numerous settings
considered in our analyses where the type I error rate did not
Figure 4. Type I error rate by case genotyping error rate and sample size. An example of how the Type I error rate changes by sample size
and amount of differential genotyping error. Notably, as the amount of differential genotyping error increases, and as the sample size increases, the
Type I error rate increases. Here we show results from the PR test with a control genotype error rate of 0.1%, e01 = e10, 8 SNVs, with 6 SNVs at
MAF= 0.1% and 2 SNVs at MAF= 1%. Different values for the case error rate vary along the x-axis.
doi:10.1371/journal.pone.0056626.g004
Figure 5. Type I error rate variability by error model for a gene with 8 SNVs. Figure 5 considers a gene containing 8 rare variants. All error
models have control error rates fixed at e10 = 1% and e01 = 0.1%. For error model A cases: e10 = 1.1%, e01 = 0.2%, error model B is cases: e10 = 1.3%,
e01 = 0.4%, error model C is cases: e10 = 1.5%, e01 = 0.6% and error model D is cases: e10 = 2.0%, e01 = 1.1%. Type I error increases for all error models as
the genotyping error rate increases.
doi:10.1371/journal.pone.0056626.g005
Impact of Differential Errors
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inflate. In general, these settings were when the sample size was
small, the MAF was large and the differential genotyping errors
impacted the heterozygote to homozygote genotyping errors.
While important to note that type I errors will not always inflate in
the presence of differential genotyping errors, power will also tend
to be low in many such studies. Essentially, as the overall power of
a study increases, so does the potential that the study is impacted
by an inflated type I error rate.
Despite the rush to justify the existence of next-generation
sequencing data, caution and attention to quality study design
techniques will be critical. This means researchers must ensure
random assignment of cases and controls to sequencing locations
and using basic quality control procedures on sequencing data. For
example, Q–Q plots are commonly used to detect large-scale type
I error problems (e.g., from population stratification), and thus are
a practical way to detect data-set wide type I error problems. Of
Figure 6. Type I error rate variability by error model for a gene with 32 SNVs. Figure 6 considers a gene containing 32 rare variants and
considers the same error models as are in Figure 5.
doi:10.1371/journal.pone.0056626.g006
Figure 7. Type I error rate variability across additional error models: a gene with 8 SNVs. Figure 7 considers loci with 8 rare variants. All
error models have controls: e10 = 10% and e01 = 1%. For error model E cases: e10 = 10.1%, e01 = 1.1%, error model F is cases: e10 = 10.3%, e01 = 1.3%,
error model G is cases: e10 = 10.5%, e01 = 1.5% and error model H is cases: e10 = 11.0%, e01 = 2%.
doi:10.1371/journal.pone.0056626.g007
Impact of Differential Errors
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course, individual loci that may be affected by type I errors will not
be identified by this approach, which underscores that careful
design strategies still must be employed, and replication of
significant findings is necessary. Furthermore, there are a host
general quality control steps that should be taken in an NGS study.
While best-practices continue to develop, evaluating data quality
(e.g., individual SNP quality via BAM files) and designing studies
to include some redundancy (e.g., technical replicates and/or
genotyping some participants with arrays) are generally recom-
mended and may help to identify genotype errors before they
impact downstream statistical analyses.
Importantly, we note that our findings apply not only to next-
generation sequencing technology, but to imputed variants or
variants genotyped on an array as well. Our approach is not
technology specific, but considers the impact of differential errors
Figure 8. Type I error rate variability across additional error models: a gene with 32 SNVs. Figure 8 considers loci with 32 rare variants
and considers the same error models as are in Figure 7.
doi:10.1371/journal.pone.0056626.g008
Figure 9. Type I error rate variability across additional error models: a gene with 8 SNVs. Figure 9 considers loci with 8 rare variants. All
error models have controls: e10 = 50% and e01 = 5%. For error model I cases: e10 = 50.1%, e01 = 5.1%, error model J is cases: e10 = 50.3%, e01 = 5.3%, error
model K is cases: e10 = 50.5%, e01 = 5.5% and error model L is cases: e10 = 51.0%, e01 = 6%.
doi:10.1371/journal.pone.0056626.g009
Impact of Differential Errors
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on the statistical methods used to analyze rare variant data,
regardless of the technology used to generate the variant calls.
There are some limitations of our analysis worth noting. We use
simulated genotype data which ignores LD, and simplifies the true
allele frequency distribution observed in next-generation sequenc-
ing data. These simplifying assumptions are common in method-
ological papers on rare-variant tests of association proposed to
date, however further analysis is necessary to project these findings
to more realistic sequence data. Second, the goal of this paper was
not to compare which rare variant tests may be more or less
resistant to certain types of genotyping errors. Notably, in our
analyses SKAT appear to be more resistant to type I errors than
the other methods. However, SKAT was designed to perform
optimally in situations where there is a mix of signals, resulting
from a combination of neutral, protective and risk variants and has
been observed to have a conservative type I error rate in some
settings. Recent work (Liu, unpublished manuscript) also provides
a general framework for rare variant tests which classifies CMC,
PR, CMAT and WS differently than SKAT, which may also
explain some of the differences observed here. Additionally, more
complex error models should be considered as more is learned
about the error processes involved next-generation sequencing
data. Fourth, our analysis of type I errors considers a significance
level of 5%, which is unrealistic for large genome-wide studies.
Without analytic consideration of the different tests or substantially
more computation time to simulate data, estimates of type I error
rates at lower significance levels cannot be obtained. However, as
has been found with single marker tests, we have no reason to
believe that the patterns of results will be different at different
significance levels. Finally, our choice to use only additive main
effects in the multiple regression model is a simplistic one that does
not completely reflect the underlying complexity (non-linear
relationships; interactions, etc.) of the relationship between the
six parameters considered here and type I error. A more detailed
analysis should be conducted for any particular study design or
error pattern of interest. However, given that the models explained
a significant portion of the variance in the type I error rate, they
can be interpreted as giving a general sense of the true
relationships.
Our analysis has demonstrated that type I errors caused by
differential genotyping errors could be a significant problem in
rare variant tests of association applied to next-generation
sequencing data. In fact, some early application of the tests to
real sequencing data suggests this could be the case. Careful
consideration of study design, caution in meta-analysis and using
publicly available controls, and use of standard quality control
metrics is critical in an effort to minimize type I errors. Further
work is necessary to fully characterize and explore the creation
and consequences of differential genotyping errors in rare variant
tests of association.
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